Sanj K Patel - Net Worth and Insider Trading
Sanj K Patel Net Worth
The estimated net worth of Sanj K Patel is at least $3 Million dollars as of 2024-05-02. Sanj K Patel is the CHAIRMAN & CEO of Kiniksa Pharmaceuticals Ltd and owns about 162,311 shares of Kiniksa Pharmaceuticals Ltd (KNSA) stock worth over $3 Million. Details can be seen in Sanj K Patel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sanj K Patel has not made any transactions after 2024-03-07 and currently still holds the listed stock(s).
Transaction Summary of Sanj K Patel
Sanj K Patel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sanj K Patel owns 4 companies in total, including Kiniksa Pharmaceuticals Ltd (KNSA) , Syros Pharmaceuticals Inc (SYRS) , and BioCryst Pharmaceuticals Inc (BCRX) among others .
Click here to see the complete history of Sanj K Patel’s form 4 insider trades.
Insider Ownership Summary of Sanj K Patel
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
KNSA | Kiniksa Pharmaceuticals Ltd | 2024-03-07 | director & 10 percent owner & Chairman & CEO |
SYRS | Syros Pharmaceuticals Inc | 2016-06-29 | director |
BCRX | BioCryst Pharmaceuticals Inc | 2015-09-25 | director |
2014-02-17 | director |
Sanj K Patel Latest Holdings Summary
Sanj K Patel currently owns a total of 1 stock. Sanj K Patel owns 162,311 shares of Kiniksa Pharmaceuticals Ltd (KNSA) as of March 7, 2024, with a value of $3 Million.
Latest Holdings of Sanj K Patel
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
KNSA | Kiniksa Pharmaceuticals Ltd | 2024-03-07 | 162,311 | 19.38 | 3,145,587 |
Holding Weightings of Sanj K Patel
Sanj K Patel Form 4 Trading Tracker
According to the SEC Form 4 filings, Sanj K Patel has made a total of 5 transactions in Kiniksa Pharmaceuticals Ltd (KNSA) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Kiniksa Pharmaceuticals Ltd is the sale of 65,012 shares on March 7, 2024, which brought Sanj K Patel around $1 Million.
Insider Trading History of Sanj K Patel
- 1
Sanj K Patel Trading Performance
Sanj K Patel Ownership Network
Ownership Network List of Sanj K Patel
Ownership Network Relation of Sanj K Patel
Sanj K Patel Owned Company Details
What does Kiniksa Pharmaceuticals Ltd do?
Who are the key executives at Kiniksa Pharmaceuticals Ltd?
Sanj K Patel is the director & 10 percent owner & Chairman & CEO of Kiniksa Pharmaceuticals Ltd. Other key executives at Kiniksa Pharmaceuticals Ltd include Chief Accounting Officer Michael R Megna , Chief Medical Officer John Paolini , and Chief Business Officer Eben Tessari .
Kiniksa Pharmaceuticals Ltd (KNSA) Insider Trades Summary
Over the past 18 months, Sanj K Patel made 2 insider transaction in Kiniksa Pharmaceuticals Ltd (KNSA) with a net sale of 83,336. Other recent insider transactions involving Kiniksa Pharmaceuticals Ltd (KNSA) include a net sale of 96,513 shares made by John Paolini , a net sale of 24,101 shares made by Michael R Megna , and a net sale of 21,959 shares made by Barry D Quart .
In summary, during the past 3 months, insiders sold 108,277 shares of Kiniksa Pharmaceuticals Ltd (KNSA) in total and bought 0 shares, with a net sale of 108,277 shares. During the past 18 months, 225,909 shares of Kiniksa Pharmaceuticals Ltd (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 225,909 shares.
Kiniksa Pharmaceuticals Ltd (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kiniksa Pharmaceuticals Ltd Insider Transactions
Sanj K Patel Mailing Address
Above is the net worth, insider trading, and ownership report for Sanj K Patel. You might contact Sanj K Patel via mailing address: C/o Kiniksa Pharmaceuticals, Ltd., Clarendon House, 2 Church Street, Hamilton D0 Hm11.